Meridian Bioscience (VIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2022 | 09-2021 | 09-2020 | 09-2019 | 09-2018 | |
| Sales | 333,018 | 317,896 | 253,667 | 201,014 | 213,571 |
| Cost of Goods | 144,662 | 116,748 | 97,419 | 82,286 | 82,538 |
| Gross Profit | 188,356 | 201,148 | 156,248 | 118,728 | 131,033 |
| Operating Expenses | 134,627 | 108,862 | 95,343 | 86,315 | 99,987 |
| Operating Income | 54,391 | 93,034 | 61,324 | 32,699 | 31,584 |
| Interest Expense | 1,189 | 1,878 | 2,632 | 1,945 | 1,520 |
| Other Income | 1,115 | -705 | 601 | 803 | 316 |
| Pre-tax Income | 54,317 | 90,451 | 59,293 | 31,557 | 30,380 |
| Income Tax | 11,858 | 19,044 | 13,107 | 7,175 | 6,531 |
| Net Income Continuous | 42,459 | 71,407 | 46,186 | 24,382 | 23,849 |
| Net Income | $42,459 | $71,407 | $46,186 | $24,382 | $23,849 |
| EPS Basic Total Ops | 0.97 | 1.65 | 1.08 | 0.57 | 0.56 |
| EPS Basic Continuous Ops | 0.97 | 1.65 | 1.08 | 0.57 | 0.56 |
| EPS Diluted Total Ops | 0.96 | 1.62 | 1.07 | 0.57 | 0.56 |
| EPS Diluted Continuous Ops | 0.96 | 1.62 | 1.07 | 0.57 | 0.56 |
| EPS Diluted Before Non-Recurring Items | 1.38 | 1.66 | 1.07 | 0.68 | 0.74 |
| EBITDA(a) | $70,902 | $108,320 | $74,891 | $42,663 | $40,272 |